A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Therapeutic Advances in Childhood Leukemia Consortium
Sponsor:
Collaborators:
Gateway for Cancer Research
University of Southern California
Information provided by (Responsible Party):
Weili Sun, Children's Hospital Los Angeles
ClinicalTrials.gov Identifier:
NCT01861002
First received: May 21, 2013
Last updated: January 31, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)